凯姆布雷克斯

CBM NYSE
44.88
+0.27
+0.61%
盘后: 44.88 0 0.00% 17:53 07/17 EDT
开盘
44.48
昨收
44.61
最高
45.08
最低
44.05
成交量
12.39万
成交均量(3M)
20.78万
52周最高
69.43
52周最低
33.80
换手率
0.37%
市值
15.10亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供凯姆布雷克斯 CBM股票价格,凯姆布雷克斯股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the subsidiaries, including Cambrex Charles City, Inc., Cambrex Karlskoga AB and Cambrex Profarmaco Milano S.r.l. Its products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It delivers services, such as custom organic synthesis and process development; current good manufacturing practices (cGMP) manufacturing of API and intermediates from grams to hundreds of kilograms; cGMP analytical services; controlled substance research and development (R&D) and manufacture, Schedule II-V, and contract research. It has API R&D and cGMP facilities in the United States and Europe. It supplies over 90 generic APIs.
展开 >

最近浏览

名称
价格
涨跌幅